ADAM17 is a member of the A Disintegrin And Metalloproteinase family of proteases. It is ubiquitously expressed and causes the shedding of a broad spectrum of surface proteins such as adhesion molecules, cytokines and cytokine receptors. By controlled shedding of these proteins from leukocytes, ADAM17 is able to regulate immune responses. Several ADAM17 targets on T cells have been implicated in T-cell migration, differentiation and effector functions. However, the role of ADAM17 in T-cell responses is still unclear. To characterize the function of ADAM17 in T cells, we used Adam17 teria-specific CD4 + T H1 and CD8 + T-cell responses and were able to control primary and secondary infections. In conclusion, our study indicates that ADAM17 is either not required in T cells under homoeostatic conditions and for control of listeria infection or can be effectively compensated by other mechanisms.
Introduction
Proteases of the ADAM (A Disintegrin And Metalloproteinase) family regulate various aspects of immune cell development and function. ADAM proteases cause the release of cytokines but also the ectodomain shedding of cell surface molecules including adhesion molecules and cytokine receptors [1, 2] . For ADAM17, more than 70 target proteins have been identified [2] . ADAM17 is responsible for the TNF-α release and thus for the paracrine and systemic activity of the cytokine [3, 4] . Inhibition of ADAM17 as well as global or myeloid cell-restricted deletion of ADAM17 in mice results in reduced systemic TNF-α levels following LPS treatment and protects mice from fatal endotoxemia [5, 6, 7] . Similarly, mice with defective iRhom2 (inactive Rhomboid protein 2), which facilitates trafficking of ADAM17 to the cell surface, are also less susceptible to LPS endotoxemia [8, 9] . ADAM17 has also been identified as sheddase for TNFR1 and TNFR2 [5, 10, 11, 12] . Loss of functional TNFRs reduces on one hand the a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 sensitivity of cells towards TNF-α, on the other hand, soluble TNFRs sequester TNF-α and thereby limit its activity. Under inflammatory conditions, the IL-6Rα chain is also shed by ADAM17 [5] . In contrast to TNF-α, binding of IL-6 by soluble (s)IL-6Rα does not result in IL-6 neutralization, rather, the IL-6/sIL-6Rα can still interact with gp130 on the surface of cells and induce IL-6 signaling. Since gp130 is ubiquitously expressed, this IL-6 trans-signaling considerably widens the spectrum of IL-6 target cells [13] . Following various stimuli, L-selectin (CD62L) is rapidly shed from neutrophils and lymphocytes by ADAM17, and neutrophils deficient in ADAM17 show altered rolling and adhesion to endothelia and accelerated accumulation in the inflamed peritoneum [14, 15, 16] .
Mouse T cells constitutively express Adam17 mRNA [17] and we could recently demonstrate impaired shedding of ADAM17 targets in T cells from hypomorphic ADAM17 mice with substantially reduced ADAM17 expression or in T cells cultured with ADAM17 inhibitors [5] . ADAM17 targets are involved in diverse T-cell functions including migration and differentiation to effector cells, therefore it has been postulated that ADAM17-mediated shedding of these proteins can regulate these processes [2, 18] . Here, we use mice with a T-cell restricted ADAM17-deficiency (Adam17 αCD4cre -control mice of 8 to 12 weeks of age were used in all experiments. Mice were intravenously infected with wildtype Listeria monocytogenes strain EGD or a L. monocytogenes strain recombinant for ovalbumin [19] . Mice received 2α10 4 listeria in 200 μl PBS. Bacterial inocula were controlled by plating serial dilutions on PALCAM agar plates. For determination of bacterial burdens in infected mice, spleens and livers were homogenized in H 2 O, 0.5% Triton X-100 and serial dilutions of homogenates were plated on PALCAM agar. Colonies were counted after incubation at room temperature. This study was carried out in strict accordance with the state guidelines. The protocol was approved by local ethics committee of the Behörde für Gesundheit und Verbraucherschutz of the City of Hamburg (Permit Number: 81/14). Mice were housed under specific pathogen free conditions in individually ventilated cages with standard food and water ad libitum. During infection experiments, mice were controlled daily and mice with signs of severe disease were euthanized to minimize suffering.
Materials and methods

Mice and Listeria monocytogenes infection
(Sigma Aldrich). Alternatively, cells were cultured in plates coated with anti-CD3 mAb (clone 145-2C11, Biolegend, San Diego, CA). The reaction was stopped at different time points (0, 30, 60, 120, 240 min) by placing the cell suspension on ice and adding ice cold PBS.
In vitro proliferation was measured by CFSE dilution assay. Spleen cells were incubated in PBS with 5μM CFSE for 15min at 37˚C. Cells were washed with PBS and 4 ×10 5 cells/well were cultured in culture medium in 96-well plates coated with anti-CD3 mAb in the presence of anti-CD28 mAb (clone 37.51, Biolegend). After three days, staining intensity of CFSE on CD4 + and CD8 + T cells was determined by flow cytometry. In parallel, cells were restimulated with 50 ng/ml PMA and 1 μM ionomycin for 4h. For the last 3.5h, 10 μg/ml brefeldin A (Sigma Aldrich) was added to the cultures to prevent cytokine secretion. Subsequently, CD40L and cytokine expression was determined by intracellular mAb staining and flow cytometry. For the induction of cytokines, lymphocytes from spleen and liver cells were incubated at 1×10 6 cells/ml in culture medium. Cells were stimulated for 4 h with 10 −6 M ovalbumin peptide (OVA 257-264 ; SIINFEKL) and 10 −5 M listeriolysin O peptide (LLO 189-201 ; WNEKYA-QAYPNVS) (both JPT, Berlin, Germany), or with PMA and ionomycin. 10 μg/ml brefeldin A was added for the last 3.5 h of culture. Subsequently, cells were analyzed by flow cytometry [21, 22, 23] .
In vivo cytotoxicity assay
Spleen cells from C57BL/6 mice were incubated in culture medium with 10 Spleen cells were also incubated in plates coated with anti-CD3 mAb and surface expression of CD62L, IL-6Rα and TNFR1 was determined (Fig 2) . In comparison to PMA and ionomycin treatment, shedding of these proteins was less pronounced and delayed after anti-CD3 mAb treatment. However, we also observed impaired shedding of CD62L, IL-6Rα and TNFR1 from T cells from Adam17 (Fig 3B) . In some experiments, we observed slightly reduced CD4 + and increased CD8 + T-cell frequencies, however, these alterations were not consistent in all experiments. T cells from spleen, lymph nodes and liver were stained for CD44 and CD62L to determine the distribution of naive (CD44 In summary, ADAM17 deficiency did not substantially alter the in vitro T-cell response to polyclonal stimulation. In some assays, ADAM17-deficient T cells showed stronger responses, however, differences were in all cases only very modest. T-cell responses generated during L. monocytogenes infection of C57BL/6 mice. Compared to naive mice (Fig 3) , we observed a shift in frequencies and numbers from CD44 -CD62L + naive to CD44 + CD62L -effector CD4 + and CD8 + T cells in spleen (Fig 4A and   4C ) and liver (Fig 4B and 4D) The role of ADAM17 in the T-cell response against bacterial pathogens 
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-mice (Fig 5A and 5B) . In some experiments, we observed slightly higher frequencies of cytokine producing CD8 + T cells in the liver of Adam17 (Fig 6A and 6B) .
Cells from listeria-infected mice Adam17
fl/fl ×CD4cre + were also polyclonally stimulated with PMA/ionomycin to test whether ADAM17-deficiency resulted in a general shift in the cytokine response of CD4 + T cells (Fig 6C-6F) . Again, we detected comparable frequencies of IFN-γ + TNF-α + CD40L + T H1 cells (Fig 6D) Finally, the cytolytic activity of CD8 + T cells was tested (Fig 7) . Adam17 
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Discussion
ADAM17 is constitutively expressed in T cells and expression only marginally changes following T-cell activation [17] . Functional characterization of ADAM17-deficient T cells in vitro due to infection, which further confirms that ADAM17-deficiency does not substantially weakens the T-cell response to L. monocytogenes. Naive and memory T cells require the addressin CD62L for entering the T-cell zone of secondary lymphoid tissues at high endothelial venules. Subsequent activation in the T-cell zone causes rapid loss of CD62L surface expression. Our in vitro experiments demonstrate that CD62L shedding from T cells is strictly dependent on ADAM17. However, we did not observe substantial changes in T-cell development and distribution as well as in the T-cell response to L. monocytogenes. Our results confirm studies demonstrating normal homeostatic T-cell distribution in mice with a protease resistant CD62L protein [28, 29] . Thus, rapid CD62L shedding from activated T cells appears to be not essential for their function. mRNA expression analyses indicate that activated CD8 + T cells downregulate Sell mRNA (coding for CD62L) during listeria infection [17] , which might compensate for defective shedding. We observed impaired shedding of TNF-α and TNFRI, and delayed shedding of TNFRII from T cells of Adam17 fl/fl ×CD4cre + mice. These defects did neither interfere with T-cell differentiation under homeostatic conditions nor with formation of a T-cell response against L. monocytogenes. Shedding of TNF-α from T cells was also not required for listeria control during primary and secondary infection. In the case of TNFRI and TNFRII other protease might compensate for the ADAM17-deficiency in T cells. Several studies could demonstrate that membrane-bound TNF-α is active [30, 31, 32, 33, 34] and capable of providing partial protection against L. monocytogenes infection [27, 31, 33] . In addition, protection against listeria mainly relies on TNF-α produced by myeloid cells and only under conditions with high titers, T-cell derived TNF-α becomes important [26] . Finally, control of secondary listeria infection does not require TNF-α [26, 35] . Together, these results could well explain why a defect in shedding of TNF-α in Adam17 fl/fl ×CD4cre + mice does not substantially impair the control of L. monocytogenes.
IL-6 supports the formation of T H17 cells and suppresses the induction of peripheral T reg cells [36, 37, 38, 39] . Furthermore, there is controversial data on the role of IL-6 in T H1 responses [40, 41] . Based on these studies, one could postulate that IL-6Rα shedding restricts the response of activated CD4
+ T cells to IL-6 and thereby regulates CD4 + T-cell differentiation. In our in vitro study, we observe impaired IL-6Rα shedding from T cells of Adam17 fl/fl ×CD4cre + mice which is consistent with our results from experiments with T cells of hypomorphic ADAM17 mice or with metalloprotease inhibitors [5] . However, ADAM17-deficiency affected neither the composition of T-cell subsets under homeostatic conditions nor the formation of the T-cell response against L. monocytogenes. Listeria infection of mice is considered to be a T H1 model and thus provides only very limited information on T H17 -cell differentiation. In addition, it could recently be shown that T H17 differentiation requires IL-6 presentation by IL-6Rα + dendritic cells and is largely independent from IL-6Rα expression on T cells [38] . However, Adam17 fl/fl ×CD4cre + mice also showed normal frequencies of T reg cells and generated a regular T H1 and CD8 + T-cell response to L.
monocytogenes. Thus, ADAM17-mediated shedding of IL-6Rα is either not important for these processes or compensated by other mechanisms such as shedding by other proteases, receptor internalization or down-regulation of Il6Ra mRNA expression in activated T cells [5, 17] .
In conclusion, our study indicates that although T cells bear several potential ADAM17 targets on their surface, ADAM17-deficiency does not result in profound changes of peripheral T-cell composition under homeostatic conditions and does not impair the T H1 and CD8 + Tcell response against L. monocytogenes. ADAM17-mediated shedding might simply be not required in these processes. Alternatively, ADAM17 targets could be shed by other proteases, removed from the cell surface by internalization or downregulated on the mRNA expression level. Our analysis was restricted to the T-cell response against L. monocytogenes. However, it is well conceivable that under different circumstances, such as responses to other pathogens or to tumors or in autoimmunity, T cells might require ADAM17 for proper function.
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